We previously reported that fulvestrant also induces modification of ERα by small ubiquitin-related modifiers 1/2/3 (SUMO1/2/3) in ER+ breast cancer cells and identified four SUMO-modified sites in human ERα by mass spectrometry (37). The gene discussed is ESR1; the disease is breast carcinoma.